| | Variables/groups | Unvaccinated
() | Unvaccinated previously PCR+
() | BNT162b2 one dose
() | BBIBP-CorV one dose
() | BNT162b2 two doses
() | BBIBP-CorV two doses
() | BNT162b2 booster dose () |
| | Age in years | 25.18 (19.96, 30.41) | 26.62 (18.67, 34.56) | 28.14 (23.34, 32.94) | 32.62 (26.55, 38.69) | 29.96 (25.29, 34.63) | 25.83 (23.01, 28.66) | 23.67 (21.49, 25.84) |
| | Gender | | | | | | | | | Males | 45% | 8% | 52% | 38% | 63% | 62% | 20% | | Females | 55% | 92% | 48% | 62% | 37% | 38% | 80% |
| | Height in centimeters | 167.4 (163.4, 171.3) | 164.7 (160.1, 169.2) | 169.7 (166.3, 173.1) | 167.2 (164.1, 170.4) | 172.7 (168.7, 176.6) | 173.3 (168.9, 177.6) | 166.8 (162.6, 171.0) |
| | Weight in kilograms | 67.80 (61.34, 74.26) | 66.31 (54.01, 78.60) | 69.85 (64.07, 75.64) | 67.00 (62.93, 71.07) | 74.31 (66.73, 81.88) | 72.25 (65.36, 79.14) | 59.27 (55.05, 63.48) |
| | Time since the latest infection or vaccine dose in days | NA | 187.1 (133.3, 240.9) | 34.34 (23.66, 45.03) | 102.7 (82.87, 122.5) | 113.4 (80.46, 146.4) | 72.46 (60.47, 84.45) | 67.07 (29.83, 104.3) |
| Local symptoms after vaccination
(1) Pain
(2) Swelling
(3) Redness
(4) Itch | NA | NA | (1) 73%
(2) 19%
(3) 8%
(4) 15% | (1) 31%
(2) 6%
(3) 0%
(4) 6% | (1) 90%
(2) 0%
(3) 0%
(4) 10% | (1) 58%
(2) 0%
(3) 0%
(4) 0% | (1) 87%
(2) 0%
(3) 7%
(4)0% |
| Systemic symptoms after vaccination
(1) Fever
(2) Fatigue
(3) Headache
(4) Chills
(5) Vomiting
(6) Diarrhea
(7) Muscle pain
(8) Joint pain | NA | NA | (1) 23%
(2) 42%
(3) 29%
(4) 4%
(5) 0%
(6) 0%
(7) 42%
(8) 12% | (1) 13%
(2) 31%
(3) 13%
(4) 6%
(5) 0%
(6) 0%
(7) 13%
(8) 13% | (1) 25%
(2) 65%
(3) 30%
(4) 10%
(5) 0%
(6) 5%
(7) 45%
(8) 35% | (1) 17%
(2) 8%
(3) 17%
(4) 8%
(5) 0%
(6) 0%
(7) 8%
(8) 8% | (1) 33%
(2) 40%
(3) 27%
(4) 27%
(5) 0%
(6) 0%
(7) 20%
(8) 13% |
|
|
